Fan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Recognitions
Fan Zhang has a total of 681 co-authors. Here are the top co-authors by number of shared publications:
- Soumya Raychaudhuri
Center for Data Sciences, Brigham and Women’s Hospital, Boston, USA
23 shared publications - Michael B. Brenner
Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
18 shared publications - Jennifer Howitt Anolik
Department of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, NY 14642, USA
12 shared publications - Anna Helena Jonsson
Division of Rheumatology, The University of Colorado Anschutz Medical Campus, Aurora, USA
11 shared publications - Deepak A. Rao
Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
11 shared publications - Laura T. Donlin
Immunology and Microbial Pathogenesis Graduate Program, Weill Cornell Graduate School, New York, NY 10065, USA
11 shared publications
Latest Publications
- 27 October 2026
- Published by Springer Nature in Nature Reviews Rheumatology
- p. 1-15
Towards rheumatoid arthritis prevention: integrating mechanistic and omics insights
Seropositive rheumatoid arthritis (RA) is an autoimmune disease whose course typically begins before joint involvement, during a period termed pre-RA, which is initially characterized by the presence of autoantibodies, including anti-citrullinated protein antibodies and rheumatoid factors. The ability to identify autoantibody-positive individuals who are at an increased risk of developing clinical RA has catalysed efforts to define the immune mechanisms underlying the initial break in self-tolerance and the subsequent transition to clinically apparent disease. Although not mutually exclusive, these investigations have broadly followed two complementary approaches: hypothesis-testing studies and agnostic multi-omics analysis. Hypothesis-testing studies have identified site-specific and isotype-specific patterns of mucosal anti-citrullinated protein antibodies and rheumatoid factor production, together with inflammation and/or dysbiosis associated with systemic autoimmunity, supporting a ‘mucosal origins hypothesis’. Cross-sectional and longitudinal multi-omics studies have demonstrated epitope spreading, pro-inflammatory biomarkers and dysregulated peripheral blood immune-cell populations with autoimmune characteristics. Epidemiological studies have further implicated certain environmental exposures in RA development. Collectively, these observations suggest that integrating molecular, cellular and environmental data through emerging data science and artificial intelligence approaches could help to identify pathogenic mechanisms underlying RA development and inform future prevention strategies.
- 27 October 2026
- Published by Springer Nature in Nature Reviews Rheumatology
- p. 1-15
Towards rheumatoid arthritis prevention: integrating mechanistic and omics insights
Seropositive rheumatoid arthritis (RA) is an autoimmune disease whose course typically begins before joint involvement, during a period termed pre-RA, which is initially characterized by the presence of autoantibodies, including anti-citrullinated protein antibodies and rheumatoid factors. The ability to identify autoantibody-positive individuals who are at an increased risk of developing clinical RA has catalysed efforts to define the immune mechanisms underlying the initial break in self-tolerance and the subsequent transition to clinically apparent disease. Although not mutually exclusive, these investigations have broadly followed two complementary approaches: hypothesis-testing studies and agnostic multi-omics analysis. Hypothesis-testing studies have identified site-specific and isotype-specific patterns of mucosal anti-citrullinated protein antibodies and rheumatoid factor production, together with inflammation and/or dysbiosis associated with systemic autoimmunity, supporting a ‘mucosal origins hypothesis’. Cross-sectional and longitudinal multi-omics studies have demonstrated epitope spreading, pro-inflammatory biomarkers and dysregulated peripheral blood immune-cell populations with autoimmune characteristics. Epidemiological studies have further implicated certain environmental exposures in RA development. Collectively, these observations suggest that integrating molecular, cellular and environmental data through emerging data science and artificial intelligence approaches could help to identify pathogenic mechanisms underlying RA development and inform future prevention strategies.
- Top Cited Papers
- 24 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (855) , eaed3087
SPP1 hi macrophages in fibrin niches promote hyperplastic tissue remodeling in rheumatoid arthritis synovium
In chronic inflammatory diseases, maladaptive tissue remodeling is driven by a complex interplay of resident cells, immune infiltrates, and the extracellular matrix. In the autoimmune disorder rheumatoid arthritis (RA), synovial tissue undergoes massive expansion to form an invasive pannus that drives the erosion of cartilage and bone. The mechanisms mediating this aggressive growth are incompletely defined. Using spatial transcriptomic profiling of patient tissue, we detected an abundance of proliferating fibroblasts near the synovial tissue lining surface and adjacent to macrophages expressing high levels of secreted phosophoprotein-1 (encoding osteopontin; SPP1 hi macrophages). These synovial lining regions were also distinctly marked by deposits of the clot-forming protein fibrin. Although the SPP1 hi macrophages phenotypically resembled the profibrotic macrophages that drive lung and liver fibrosis, these niches were devoid of the dense highly ordered collagen that marks fibrosis. Functionally, we found that SPP1 hi macrophages degraded and phagocytosed fibrin matrices and promoted fibroblast proliferation. Given that fibrin provides transient matrices for de novo tissue generation in the context of wound healing, these data support a model of hyperplastic tissue outgrowth involving SPP1 hi macrophages, fibroblasts, and fibrin matrices adhered to the exterior synovial tissue surface. Whereas current RA therapies primarily aim to dampen proinflammatory responses, our findings provide the rationale for targeting progenerative pathways and SPP1 hi macrophages.
- 24 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (855) , eaed3087
Top Cited PapersSPP1 hi macrophages in fibrin niches promote hyperplastic tissue remodeling in rheumatoid arthritis synovium
In chronic inflammatory diseases, maladaptive tissue remodeling is driven by a complex interplay of resident cells, immune infiltrates, and the extracellular matrix. In the autoimmune disorder rheumatoid arthritis (RA), synovial tissue undergoes massive expansion to form an invasive pannus that drives the erosion of cartilage and bone. The mechanisms mediating this aggressive growth are incompletely defined. Using spatial transcriptomic profiling of patient tissue, we detected an abundance of proliferating fibroblasts near the synovial tissue lining surface and adjacent to macrophages expressing high levels of secreted phosophoprotein-1 (encoding osteopontin; SPP1 hi macrophages). These synovial lining regions were also distinctly marked by deposits of the clot-forming protein fibrin. Although the SPP1 hi macrophages phenotypically resembled the profibrotic macrophages that drive lung and liver fibrosis, these niches were devoid of the dense highly ordered collagen that marks fibrosis. Functionally, we found that SPP1 hi macrophages degraded and phagocytosed fibrin matrices and promoted fibroblast proliferation. Given that fibrin provides transient matrices for de novo tissue generation in the context of wound healing, these data support a model of hyperplastic tissue outgrowth involving SPP1 hi macrophages, fibroblasts, and fibrin matrices adhered to the exterior synovial tissue surface. Whereas current RA therapies primarily aim to dampen proinflammatory responses, our findings provide the rationale for targeting progenerative pathways and SPP1 hi macrophages.
- Open Access
scLASER: a robust framework for simulating and detecting time-dependent single-cell dynamics in longitudinal studies
Longitudinal single-cell clinical studies enable tracking within-individual cellular dynamics, but methods for modeling temporal phenotypic changes and estimating power remain limited. We present scLASER, a framework detecting time-dependent cellular neighborhood dynamics and simulating longitudinal single-cell datasets for power estimation. Across benchmark experiments, scLASER shows consistently higher sensitivity than traditional cluster--based approaches, with particularly pronounced gains in rare cell types and non-linear temporal patterns. Applications to inflammatory bowel disease (95,813 cells, 38 patients) reveal treatment-responsive NOTCH3+ stromal trajectories with high cell type discrimination (AUC > 0.92), while analysis of COVID-19 data (188,181 cells, 84 patients) identifies three distinct axes of T cell activity (cytotoxic effector, NK immunoreceptor signaling, and interferon-stimulated gene programs) over disease progression. scLASER enables robust longitudinal single-cell analysis and optimization of study design. Teaser: A new framework detects time-dependent cellular dynamics and enables power estimation for longitudinal clinical single-cell studies.
Open AccessscLASER: a robust framework for simulating and detecting time-dependent single-cell dynamics in longitudinal studies
Longitudinal single-cell clinical studies enable tracking within-individual cellular dynamics, but methods for modeling temporal phenotypic changes and estimating power remain limited. We present scLASER, a framework detecting time-dependent cellular neighborhood dynamics and simulating longitudinal single-cell datasets for power estimation. Across benchmark experiments, scLASER shows consistently higher sensitivity than traditional cluster--based approaches, with particularly pronounced gains in rare cell types and non-linear temporal patterns. Applications to inflammatory bowel disease (95,813 cells, 38 patients) reveal treatment-responsive NOTCH3+ stromal trajectories with high cell type discrimination (AUC > 0.92), while analysis of COVID-19 data (188,181 cells, 84 patients) identifies three distinct axes of T cell activity (cytotoxic effector, NK immunoreceptor signaling, and interferon-stimulated gene programs) over disease progression. scLASER enables robust longitudinal single-cell analysis and optimization of study design. Teaser: A new framework detects time-dependent cellular dynamics and enables power estimation for longitudinal clinical single-cell studies.
- Open Access
Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversion
Individuals who have serum elevations of anti-cyclic citrullinated protein (anti-CCP) antibodies are at risk for developing rheumatoid arthritis (RA), yet immunologic factors that lead to a transition from pre- to clinical RA remain unclear. Here, we used materials from anti-CCP antibody-positive individuals enrolled in a clinical trial that evaluated the efficacy of hydroxychloroquine to prevent clinical RA, and performed multi-modal single-cell profiling (transcriptome, surface proteins, T/B-cell receptor sequencing, and chromatin accessibility) on samples obtained at baseline and at RA onset in those who developed clinical RA (Converters) or follow-up point in matched Nonconverters. At both baseline and follow-up, Converters had expansions of peripheral helper T (Tph) cells and CD8 + T cells expressing GZMK and GZMB , along with elevated potentially autoreactive T-cell receptors in CD4 + T cells compared to Nonconverters. Induction of age-associated B cell signatures was observed in B cells of Converters prior to RA onset. Epigenetic profiling further identified chromatin accessibility changes in Converters over time, particularly within myeloid and NK cells. Lastly, predictive modeling using baseline immune features, including Tph cells, GZMK + XCL1 + CD8 + , and GZMB + CD57 + CD8 + T cells, together with clinical features such as anti-CCP3 levels, RF-positivity, and HLA shared epitope status, stratified RA risk and predicted time to onset. These findings define immune endotypes in pre-RA that could serve as targets for future preventive interventions and be used to stratify the risk of developing clinical RA in anti-CCP antibody-positive individuals.
Open AccessLongitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversion
Individuals who have serum elevations of anti-cyclic citrullinated protein (anti-CCP) antibodies are at risk for developing rheumatoid arthritis (RA), yet immunologic factors that lead to a transition from pre- to clinical RA remain unclear. Here, we used materials from anti-CCP antibody-positive individuals enrolled in a clinical trial that evaluated the efficacy of hydroxychloroquine to prevent clinical RA, and performed multi-modal single-cell profiling (transcriptome, surface proteins, T/B-cell receptor sequencing, and chromatin accessibility) on samples obtained at baseline and at RA onset in those who developed clinical RA (Converters) or follow-up point in matched Nonconverters. At both baseline and follow-up, Converters had expansions of peripheral helper T (Tph) cells and CD8 + T cells expressing GZMK and GZMB , along with elevated potentially autoreactive T-cell receptors in CD4 + T cells compared to Nonconverters. Induction of age-associated B cell signatures was observed in B cells of Converters prior to RA onset. Epigenetic profiling further identified chromatin accessibility changes in Converters over time, particularly within myeloid and NK cells. Lastly, predictive modeling using baseline immune features, including Tph cells, GZMK + XCL1 + CD8 + , and GZMB + CD57 + CD8 + T cells, together with clinical features such as anti-CCP3 levels, RF-positivity, and HLA shared epitope status, stratified RA risk and predicted time to onset. These findings define immune endotypes in pre-RA that could serve as targets for future preventive interventions and be used to stratify the risk of developing clinical RA in anti-CCP antibody-positive individuals.
- Open Access
- 3 December 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1746667
Editorial: Systems immunology and computational omics for transformative medicine
The first theme reflects the innovative use of computational methods, multi-omics data integration, and systems-level thinking to unravel intricate biological mechanisms, particularly within immunology. The papers under this theme introduce novel algorithms, analytical pipelines, or theoretical frameworks to process large datasets and derive actionable insights from complex interactions at different biological scales.Several papers exemplify this theme. Hanson et al. present a flexible systems analysis pipeline integrating cell-segmented imaging data with multivariate modeling to analyze spatial relationships within the tumor microenvironment and their relationship to tumor or patient features. Townsend et al. evaluate and benchmark computational methods for integrating scRNA-seq with GWAS to understand immune-mediated inflammatory diseases. Quiroz et al. develop a conceptual framework for viewing the immune system as a multiscale adaptive information processing network, using principles like self-organized criticality and antifragility to understand its operation.The second theme reflects the expanded focus of computational and systems biology insights to real-world medical challenges, aiming to improve diagnostics, prognostics, and therapeutic strategies. The breadth of modern data collection and access necessitates computational techniques to identify biomarkers, predict patient outcomes, understand disease progression, and discover new therapeutic targets or interventions.Focusing most closely on translational impact, Peng et al. introduce "Idbview," a database and web platform centralizing clinical and omics data for respiratory diseases, aiming to facilitate biomarker identification and streamline research. Zhang et al. investigate the Systemic Immune-Inflammation Index as a biomarker for surgical invasiveness in robot-assisted pelvic fracture fixation, providing a clear example of informing clinical practice. Cui et al. utilize computational analysis of multi-omics and single-cell data to identify MHC-II-expressing Triple-Negative Breast Cancer (TNBC) cells and develop a prognostic gene signature with translational potential.Systems approaches may also contribute to the interpretation and use of molecular characterization from the laboratory. Datta et al. developed a human in vitro model to study the tumor microenvironmental effects of Axl inhibition to inform clinical trial design. This intervention has complex and context-dependent effects that can only be understood through multivariate analysis. Liu et al. combine genetic analyses, multi-omics, and virtual screening to identify gut microbial metabolites and druggable targets, such as ILA binding to PFKFB2 for sepsis treatment, directly contributing to therapeutic development.Collectively, the articles in this series highlight two complementary directions in systems immunology: the development of advanced computational frameworks to dissect immune complexity, and the translation of these insights into clinical contexts for biomarker discovery and therapeutic application. Continued progress will rely on close collaboration across computational, experimental, and clinical disciplines. Together, these studies demonstrate the growing impact of systems immunology in driving precision medicine.
- 3 December 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1746667
Open AccessEditorial: Systems immunology and computational omics for transformative medicine
The first theme reflects the innovative use of computational methods, multi-omics data integration, and systems-level thinking to unravel intricate biological mechanisms, particularly within immunology. The papers under this theme introduce novel algorithms, analytical pipelines, or theoretical frameworks to process large datasets and derive actionable insights from complex interactions at different biological scales.Several papers exemplify this theme. Hanson et al. present a flexible systems analysis pipeline integrating cell-segmented imaging data with multivariate modeling to analyze spatial relationships within the tumor microenvironment and their relationship to tumor or patient features. Townsend et al. evaluate and benchmark computational methods for integrating scRNA-seq with GWAS to understand immune-mediated inflammatory diseases. Quiroz et al. develop a conceptual framework for viewing the immune system as a multiscale adaptive information processing network, using principles like self-organized criticality and antifragility to understand its operation.The second theme reflects the expanded focus of computational and systems biology insights to real-world medical challenges, aiming to improve diagnostics, prognostics, and therapeutic strategies. The breadth of modern data collection and access necessitates computational techniques to identify biomarkers, predict patient outcomes, understand disease progression, and discover new therapeutic targets or interventions.Focusing most closely on translational impact, Peng et al. introduce "Idbview," a database and web platform centralizing clinical and omics data for respiratory diseases, aiming to facilitate biomarker identification and streamline research. Zhang et al. investigate the Systemic Immune-Inflammation Index as a biomarker for surgical invasiveness in robot-assisted pelvic fracture fixation, providing a clear example of informing clinical practice. Cui et al. utilize computational analysis of multi-omics and single-cell data to identify MHC-II-expressing Triple-Negative Breast Cancer (TNBC) cells and develop a prognostic gene signature with translational potential.Systems approaches may also contribute to the interpretation and use of molecular characterization from the laboratory. Datta et al. developed a human in vitro model to study the tumor microenvironmental effects of Axl inhibition to inform clinical trial design. This intervention has complex and context-dependent effects that can only be understood through multivariate analysis. Liu et al. combine genetic analyses, multi-omics, and virtual screening to identify gut microbial metabolites and druggable targets, such as ILA binding to PFKFB2 for sepsis treatment, directly contributing to therapeutic development.Collectively, the articles in this series highlight two complementary directions in systems immunology: the development of advanced computational frameworks to dissect immune complexity, and the translation of these insights into clinical contexts for biomarker discovery and therapeutic application. Continued progress will rely on close collaboration across computational, experimental, and clinical disciplines. Together, these studies demonstrate the growing impact of systems immunology in driving precision medicine.
- Top Cited Papers
- 24 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (817) , eadt7214
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation
Rheumatoid arthritis (RA) is preceded by an at-risk stage of disease that can be marked by the presence of anticitrullinated protein antibodies (ACPAs) but the absence of clinically apparent synovitis (clinical RA). Preemptive intervention in at-risk individuals could prevent or delay future tissue damage; however, the immunobiology of this stage is unclear. Using integrative multiomics, we longitudinally profiled at-risk individuals, where one-third of participants developed clinical RA on study. We found evidence of systemic inflammation and signatures of activation in naïve T and B cells of at-risk individuals. During progression to clinical RA, proinflammatory skewing of atypical B cells and expansion of memory CD4 T cells with signatures of activation and B cell help were present without elevations in circulating ACPA titers. Epigenetic changes in naïve CD4 T cells suggested a predisposition to differentiate into effector cells capable of B cell help. These findings characterize pathogenesis of the ACPA + at-risk stage and support the concept that the disease begins much earlier than clinical RA. Additionally, an extensive immune resource of the at-risk stage and progression to clinical RA with interactive tools was developed to enable further investigation.
- 24 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (817) , eadt7214
Top Cited PapersProgression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation
Rheumatoid arthritis (RA) is preceded by an at-risk stage of disease that can be marked by the presence of anticitrullinated protein antibodies (ACPAs) but the absence of clinically apparent synovitis (clinical RA). Preemptive intervention in at-risk individuals could prevent or delay future tissue damage; however, the immunobiology of this stage is unclear. Using integrative multiomics, we longitudinally profiled at-risk individuals, where one-third of participants developed clinical RA on study. We found evidence of systemic inflammation and signatures of activation in naïve T and B cells of at-risk individuals. During progression to clinical RA, proinflammatory skewing of atypical B cells and expansion of memory CD4 T cells with signatures of activation and B cell help were present without elevations in circulating ACPA titers. Epigenetic changes in naïve CD4 T cells suggested a predisposition to differentiate into effector cells capable of B cell help. These findings characterize pathogenesis of the ACPA + at-risk stage and support the concept that the disease begins much earlier than clinical RA. Additionally, an extensive immune resource of the at-risk stage and progression to clinical RA with interactive tools was developed to enable further investigation.
- Open Access
- 23 September 2025
- Published by Wiley in Advanced Science
- Vol. 12 (42) , e03289
CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single‐Cell Multi‐Omics
Single‐cell technologies have transformed the understanding of disease heterogeneity, but linking cell‐level phenotypic alterations to clinical outcomes becomes increasingly challenging as single‐cell datasets continue to expand. This is further complicated by the lack of interpretability in existing methods and the difficulty of detecting interaction effects—nonlinear dependencies between factors like sex, age, and disease. To address this, a novel explainable machine learning method, CellPhenoX, is developed to identify cell‐specific phenotypes and interaction effects linked to clinical outcomes. CellPhenoX integrates classification models, explainable artificial intelligence (AI) techniques, and a statistical framework to generate interpretable, cell‐specific scores to uncover condition‐associated cell populations. Extensive benchmarking and applications demonstrate the efficacy of CellPhenoX across diverse single‐cell study designs, including the dedicated and disease‐motivated simulations, binary disease‐control comparisons, and severity‐stratified patient cohorts. Notably, CellPhenoX identifies an activated monocyte phenotype in COVID‐19, with expansion correlated with disease severity after adjusting for covariates and interactive effects. It also uncovers a fibroblast‐specific state transition gradient predicting tissue inflammation in chronic diseases, and identifies therapy‐induced T cell changes and biomarkers linked to the tumor microenvironment. By integrating interpretability into clinical classification, CellPhenoX offers a powerful framework for translating single‐cell findings into clinical impact.
- 23 September 2025
- Published by Wiley in Advanced Science
- Vol. 12 (42) , e03289
Open AccessCellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single‐Cell Multi‐Omics
Single‐cell technologies have transformed the understanding of disease heterogeneity, but linking cell‐level phenotypic alterations to clinical outcomes becomes increasingly challenging as single‐cell datasets continue to expand. This is further complicated by the lack of interpretability in existing methods and the difficulty of detecting interaction effects—nonlinear dependencies between factors like sex, age, and disease. To address this, a novel explainable machine learning method, CellPhenoX, is developed to identify cell‐specific phenotypes and interaction effects linked to clinical outcomes. CellPhenoX integrates classification models, explainable artificial intelligence (AI) techniques, and a statistical framework to generate interpretable, cell‐specific scores to uncover condition‐associated cell populations. Extensive benchmarking and applications demonstrate the efficacy of CellPhenoX across diverse single‐cell study designs, including the dedicated and disease‐motivated simulations, binary disease‐control comparisons, and severity‐stratified patient cohorts. Notably, CellPhenoX identifies an activated monocyte phenotype in COVID‐19, with expansion correlated with disease severity after adjusting for covariates and interactive effects. It also uncovers a fibroblast‐specific state transition gradient predicting tissue inflammation in chronic diseases, and identifies therapy‐induced T cell changes and biomarkers linked to the tumor microenvironment. By integrating interpretability into clinical classification, CellPhenoX offers a powerful framework for translating single‐cell findings into clinical impact.
- Open Access
- 31 August 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (5)
STEAM: Spatial Transcriptomics Evaluation Algorithm and Metric for clustering performance
Spatial transcriptomic technologies allow researchers to explore the diversity and specificity of gene expression within an original tissue structure. Accurately identifying regions that are spatially coherent in both gene expression and physical tissue structures is an emerging topic; however, it is challenging because of the lack of ground truth labels which complicates the validation of clustering consistency and reproducibility. This highlights a need for a computational evaluation framework to rigorously and unbiasedly assess the clustering performance. To address this gap, we propose Spatial Transcriptomics Evaluation Algorithm and Metric (STEAM), a user-friendly computational pipeline to evaluate the consistency and reliability of clustering results by leveraging machine learning classification and prediction methods, with the goal of maintaining spatial proximity and gene expression patterns within clusters. In addition, it enables iterative correction of misclassified cells, providing actionable guidance for cluster refinement. We benchmarked STEAM on various public datasets, spanning multicell to single-cell resolution, normal and diseased tissues, as well as spatial transcriptomics and proteomics. The results highlighted its robustness and generalizability through comprehensive statistical evaluation metrics, such as Kappa score, F1 score, accuracy, adjusted rand index, normalized mutual information, and percentage of abnormal spots. Notably, STEAM supports multisample training, enabling cross-replicate clustering consistency assessments. Moreover, STEAM provides practical guidance by comparing clustering results across multiple approaches; here, we evaluated four representative methods encompassing both spatial-aware and spatial-ignorant strategies. In summary, STEAM is a promising tool for evaluating clustering robustness and benchmarking clustering performance for spatial omics data, offering valuable insights to drive reproducible discoveries in spatial biology.
- 31 August 2025
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (5)
Open AccessSTEAM: Spatial Transcriptomics Evaluation Algorithm and Metric for clustering performance
Spatial transcriptomic technologies allow researchers to explore the diversity and specificity of gene expression within an original tissue structure. Accurately identifying regions that are spatially coherent in both gene expression and physical tissue structures is an emerging topic; however, it is challenging because of the lack of ground truth labels which complicates the validation of clustering consistency and reproducibility. This highlights a need for a computational evaluation framework to rigorously and unbiasedly assess the clustering performance. To address this gap, we propose Spatial Transcriptomics Evaluation Algorithm and Metric (STEAM), a user-friendly computational pipeline to evaluate the consistency and reliability of clustering results by leveraging machine learning classification and prediction methods, with the goal of maintaining spatial proximity and gene expression patterns within clusters. In addition, it enables iterative correction of misclassified cells, providing actionable guidance for cluster refinement. We benchmarked STEAM on various public datasets, spanning multicell to single-cell resolution, normal and diseased tissues, as well as spatial transcriptomics and proteomics. The results highlighted its robustness and generalizability through comprehensive statistical evaluation metrics, such as Kappa score, F1 score, accuracy, adjusted rand index, normalized mutual information, and percentage of abnormal spots. Notably, STEAM supports multisample training, enabling cross-replicate clustering consistency assessments. Moreover, STEAM provides practical guidance by comparing clustering results across multiple approaches; here, we evaluated four representative methods encompassing both spatial-aware and spatial-ignorant strategies. In summary, STEAM is a promising tool for evaluating clustering robustness and benchmarking clustering performance for spatial omics data, offering valuable insights to drive reproducible discoveries in spatial biology.
- Open Access
Multi-modal integration of protein interactomes with genomic and molecular data discovers distinct RA endotypes
Summary: Background: Rheumatoid arthritis (RA) is a complex autoimmune disease characterized by clinical and molecular heterogeneity, notably in the presence of anti-cyclic citrullinated peptide antibodies (CCP). CCP positivity in RA patients is associated with more severe disease progression and distinct responses to treatment compared to CCP-patients. Although previous studies have investigated cellular and molecular differences between these RA subtypes, there has been limited exploration of their genetic differences at a systems scale, taking into account underlying molecular networks. Methods: Here, we use a novel multi-scale framework that couples a network-based genome-wide association study (GWAS) to functional genomic data to uncover network modules distinguishing CCP+ and CCP-RA. Findings: We utilized the RACER (Rheumatoid Arthritis Comparative Effectiveness Research) cohort, comprising 555 CCP+/RF+ and 384 CCP-/RF+ RA patients, and uncovered significant differences in heritability between these two disease groups. This was followed by a network-based GWAS which uncovered 14 putative gene modules that explained genetic differences between CCP+/RF+ and CCP-/RF+ RA. Interestingly, these included many genes outside the HLA locus. Further validation through heritability partitioning and multivariate expression analyses underscored the significance of specific modules, highlighting novel genetic loci driving heterogeneity in antibody prevalence in RA. The identified modules were validated in a completely orthogonal cohort from the All of Us program. Functional analysis revealed that these modules captured critical molecular programs that not only relate to serological variation but also underlie broader functional heterogeneity in RA, including differences in synovial cell-type abundance phenotypes and variation in treatment response. Interpretation: Our findings demonstrate the utility of network-based approaches in elucidating the complex genetic landscape of RA, offering new insights into the differential genetic risk factors underlying CCP+/RF+ and CCP-/RF+ RA, and paving the way for more personalized therapeutic strategies.
Open AccessMulti-modal integration of protein interactomes with genomic and molecular data discovers distinct RA endotypes
Summary: Background: Rheumatoid arthritis (RA) is a complex autoimmune disease characterized by clinical and molecular heterogeneity, notably in the presence of anti-cyclic citrullinated peptide antibodies (CCP). CCP positivity in RA patients is associated with more severe disease progression and distinct responses to treatment compared to CCP-patients. Although previous studies have investigated cellular and molecular differences between these RA subtypes, there has been limited exploration of their genetic differences at a systems scale, taking into account underlying molecular networks. Methods: Here, we use a novel multi-scale framework that couples a network-based genome-wide association study (GWAS) to functional genomic data to uncover network modules distinguishing CCP+ and CCP-RA. Findings: We utilized the RACER (Rheumatoid Arthritis Comparative Effectiveness Research) cohort, comprising 555 CCP+/RF+ and 384 CCP-/RF+ RA patients, and uncovered significant differences in heritability between these two disease groups. This was followed by a network-based GWAS which uncovered 14 putative gene modules that explained genetic differences between CCP+/RF+ and CCP-/RF+ RA. Interestingly, these included many genes outside the HLA locus. Further validation through heritability partitioning and multivariate expression analyses underscored the significance of specific modules, highlighting novel genetic loci driving heterogeneity in antibody prevalence in RA. The identified modules were validated in a completely orthogonal cohort from the All of Us program. Functional analysis revealed that these modules captured critical molecular programs that not only relate to serological variation but also underlie broader functional heterogeneity in RA, including differences in synovial cell-type abundance phenotypes and variation in treatment response. Interpretation: Our findings demonstrate the utility of network-based approaches in elucidating the complex genetic landscape of RA, offering new insights into the differential genetic risk factors underlying CCP+/RF+ and CCP-/RF+ RA, and paving the way for more personalized therapeutic strategies.
- Open Access
- 10 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Iterative transcription factor screening enables rapid generation of microglia-like cells from human iPSC
Differentiation of induced pluripotent stem cells (iPSCs) into specialized cell types is essential for uncovering cell-type specific molecular mechanisms and interrogating cellular function. Transcription factor screens have enabled efficient production of a few cell types; however, engineering cell types that require complex transcription factor combinations remains challenging. Here, we report an iterative, high-throughput single-cell transcription factor screening method that enables the identification of transcription factor combinations for specialized cell differentiation, which we validated by differentiating human microglia-like cells. We found that the expression of six transcription factors, SPI1, CEBPA, FLI1, MEF2C, CEBPB, and IRF8, is sufficient to differentiate human iPSC into cells with transcriptional and functional similarity to primary human microglia within 4 days. Through this screening method, we also describe a novel computational method allowing the exploration of single-cell RNA sequencing data derived from transcription factor perturbation assays to construct causal gene regulatory networks for future cell fate engineering.
- 10 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open AccessIterative transcription factor screening enables rapid generation of microglia-like cells from human iPSC
Differentiation of induced pluripotent stem cells (iPSCs) into specialized cell types is essential for uncovering cell-type specific molecular mechanisms and interrogating cellular function. Transcription factor screens have enabled efficient production of a few cell types; however, engineering cell types that require complex transcription factor combinations remains challenging. Here, we report an iterative, high-throughput single-cell transcription factor screening method that enables the identification of transcription factor combinations for specialized cell differentiation, which we validated by differentiating human microglia-like cells. We found that the expression of six transcription factors, SPI1, CEBPA, FLI1, MEF2C, CEBPB, and IRF8, is sufficient to differentiate human iPSC into cells with transcriptional and functional similarity to primary human microglia within 4 days. Through this screening method, we also describe a novel computational method allowing the exploration of single-cell RNA sequencing data derived from transcription factor perturbation assays to construct causal gene regulatory networks for future cell fate engineering.